Get startedLog in
    Picture of Bavarian Nordic A/S logo

    BAVA — Bavarian Nordic A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    All News

    Brief: Bavarian Nordic Gets Acceptance From Health Canada For Review Of New Drug Submission For Chikungunya Vaccine

    Picture of Bavarian Nordic A/S logoBavarian Nordic A/S
    22/07/2025 07:03
    July 22 (Reuters) - Bavarian Nordic A/S BAVA.CO:

BAVARIAN NORDIC RECEIVES ACCEPTANCE FROM HEALTH CANADA FOR REVIEW OF THE NEW DRUG SUBMISSION FOR ITS CHIKUNGUNYA VACCINE

REVIEW PROCEDURE BEGINS FOR CHIKUNGUNYA VACCINE, APPROVAL POSSIBLE IN 2026

Source text: ID:nGNXbBPBQ3

Further company coverage: BAVA.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com;))

    Recent news on Bavarian Nordic A/S

    See all news